Reclassification of medicines: DIORALYTE RELIEF Raspberry / Blackcurrant

Home > Notice-board > Reclassification > Dioralyte Relief Raspberry / Blackcurrant

Dioralyte Relief Raspberry / Blackcurrant

Aventis Pharma Ltd has asked the Medicines and Healthcare products Regulatory Agency to reclassify Dioralyte Relief Raspberry and Dioralyte Relief Blackcurrant as GSL medicines. The product will be licensed for the treatment of fluid and electrolyte loss associated with acute diarrhoea.

Consultation period: 25 July 2003 to 5 September 2003.

ARM 10: request to reclassify Dioralyte Relief Raspberry and Dioralyte Relief Blackcurrant from P to GSL
(Microsoft Word document)

Reclassification
P to GSL

Status
Completed